Skip to main content
Premium Trial:

Request an Annual Quote

Medicyte, Reinnervate Partner on Cell-based Assay Technologies

NEW YORK (GenomeWeb News) – Medicyte and Reinnervate today announced a collaboration to combine their technologies, bringing a next generation of cell-based assays to the biopharma and academic research markets.

The partnership brings together Medicyte's upcyte technology and Reinnervate's Alvetex Scaffold technologies. Upcyte are genetically engineered "upregulated" primary cells, and according to Medicyte, data suggests that upcyte hepatocytes combine the benefits of quantity — up to 2,000 vials per donor can be generated — and the quality of primary hepatocytes.

Alvetex Scaffold is a polystyrene product that provides a robust and inert scaffold for cells so that they can grow and form 3D structures in the laboratory.

Heidelberg, Germany-based Medicyte said that its upcyte hepatocytes "grown with a more native 3D morphology in Reinnervate's Alvetex Scaffold seem to outperform their 2D counterparts."

"The combination of both technologies will undoubtedly lead to a more predictive culture model without the limitation of cell supply," Joris Braspenning, managing director of Medicyte, said in a statement.

Reinnervate is life science firm based in the UK focused on the 3D cell culture market.

Financial and other terms of the deal were not disclosed.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.